ACE2 and inflammatory bowel disease: Except for a marginal decrease in fibrinogen and ACE2 levels in controls, routine laboratory parameters and thrombin generation did not show significant alterations when comparing blood samples obtained before and after vaccination in IBD patients and in controls.